Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- Keith A. Johnson
- , Reisa A. Sperling
- , Christopher M. Gidicsin
- , Jeremy S. Carmasin
- , Jacqueline E. Maye
- , Ralph E. Coleman
- , Eric M. Reiman
- , Marwan N. Sabbagh
- , Carl H. Sadowsky
- , Adam S. Fleisher
- , P. Murali Doraiswamy
- , Alan P. Carpenter
- , Christopher M. Clark
- , Abhinay D. Joshi
- , Ming Lu
- , Michel Grundman
- , Mark A. Mintun
- , Michel J. Pontecorvo
- , Daniel M. Skovronsky
- Massachusetts General Hospital
- Duke University
- Banner Health
- Nova Southeastern University
- University of California at San Diego
- Eli Lilly
- Global RandD Partners
Research output: Contribution to journal › Article › peer-review
238
Scopus
citations